News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ASLAN Pharmaceuticals Pte Ltd Raises $22 Million in B Round


10/10/2013 7:56:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

October 9, 2013 -- ASLAN Pharmaceuticals of Singapore completed a Series B financing that brought in $22 million, led by new investor Cenova Ventures of Shanghai and joined by two other new investors: Morningside Group and XinChen Ventures. Existing investors BioVeda Capital and Sagamore Bioventures also participated in the round. ASLAN in-licenses drugs that are at or near clinical trial stage, and then brings them through Phase II proof-of-concept, at which point the company plans to partner its drugs. More details....

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES